Navigation Links
Houston Heart Surgeon Elected Vice President of Guatemala
Date:11/5/2007

GUATEMALA CITY, Guatemala, Nov. 5 /PRNewswire/ -- World-renowned heart surgeon Dr. Rafael Espada has made history by becoming the first physician elected Vice President of Guatemala. President-elect Alvaro Colom, with Dr. Espada as his running mate, won yesterday's presidential run-off after earning more than 52.8 percent of the country's votes. The two will take office January 14, 2008.

A native of Guatemala, Dr. Espada has practiced for more than 30 years as a heart surgeon in Houston. He most recently was Deputy Chief of Cardiothoracic Surgery at the Methodist DeBakey Heart Center at The Methodist Hospital.

Dr. Espada's decision to return to Guatemala stems from his continued relationship with the country during his time in the United States. While in Houston, he established Guatemala's first cardiac hospital, Unidad Cardiovascular, which has become the premier heart hospital in Central America.

He also has traveled to Guatemala nearly every month over the last two decades to perform free surgeries for numerous Guatemalan citizens. He routinely has advised Guatemalan officials on a variety of healthcare and economic issues, including successfully mediating a strike between the government and the country's medical professionals.

Dr. Espada says his position of vice president will allow him to build on the economic development and healthcare improvements he has been working on during his time in the United States.

"A great number of Guatemalans are living in poverty, and a great number are sick and dying," says Dr. Espada. "The two problems are not mutually exclusive, and solutions go hand-in-hand. If we can create jobs and spur the economy, more people will be able to afford healthcare."

Dr. Espada's economic development plan involves creating a strong, diversified economy by creating jobs within the country and attracting more international business and investors.

"A safer, better educated country is the key to Guatemala's economic success," says the new Vice President. "We hope to put an end to the violence and corruption that has plagued our country, which will make Guatemala more attractive to foreign business."

To tackle healthcare in Guatemala, Dr. Espada seeks to improve access to preventive medicine and clean drinking water.

"The leading causes of death in Guatemala are not cancer, heart disease, or other similar conditions," the doctor says. "The illnesses killing this country are entirely preventable, and I want to make sure Guatemalans have access to the treatment, medicine and water that can save their lives."

Guatemala also suffers from one of the worst malnutrition rates in the world, affecting more than 50 percent of the country's children. Dr. Espada hopes to gain international support through the United Nations and other health organizations to help combat the problem.

Dr. Espada earned his medical degree at the Universidad San Carlos in Guatemala City, and trained as a heart surgeon under the famed Dr. Michael DeBakey in Houston.

For more information, contact Alan Bentrup at 800-559-4534 (office), 713-553-3358 (mobile) or alan@androvett.com.


'/>"/>
SOURCE Dr. Rafael Espada
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Houston Texans Star Players Ahman Green and Matt Schaub Help Easter Seals, Avondale House and Local Families Tackle Autism
2. Medical Simulation Corporation Announces Partnership with Methodist DeBakey Heart Center in Houston
3. Reliant Energy, Houston Texans Ahman Green and Matt Schaub Team to Hold News Conference, Book Signing to Raise Awareness about Autism
4. Houston Northwest Medical Centers Patient Outcomes Superior
5. Cohen Design Centers Sponsor the AIDS Walks in Los Angeles, Houston, Fort Lauderdale and New York
6. Bayer Foundation Grant Creates Graduate Engineering Fellowship at University of Houston
7. Houston Employers Hear New Research That Supports the Case for Retail Clinics
8. New St. Lukes Medical Clinic Selects Award-Winning globalcentara Provider(SM) by Houstons Global Healthcare Alliance
9. Drug for cluster headaches may cause heart problems
10. Use of certain lipid measures not more effective in predicting coronary heart disease
11. Restricting Blood Flow May Help Heart Bypass Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: